289 related articles for article (PubMed ID: 24968009)
1. A girl with tuberous sclerosis complex presenting with severe epilepsy and electrical status epilepticus during sleep, and with high-functioning autism and mutism.
Pacheva I; Panov G; Gillberg C; Neville B
Cogn Behav Neurol; 2014 Jun; 27(2):88-95. PubMed ID: 24968009
[TBL] [Abstract][Full Text] [Related]
2. Significance of tuber size for complications of tuberous sclerosis complex.
Pascual-Castroviejo I; Hernández-Moneo JL; Pascual-Pascual SI; Viaño J; Gutiérrez-Molina M; Velazquez-Fragua R; Quiñones Tapia D; Morales Bastos C
Neurologia; 2013; 28(9):550-7. PubMed ID: 23274119
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex.
Overwater IE; Rietman AB; Mous SE; Bindels-de Heus K; Rizopoulos D; Ten Hoopen LW; van der Vaart T; Jansen FE; Elgersma Y; Moll HA; de Wit MY;
Neurology; 2019 Jul; 93(2):e200-e209. PubMed ID: 31217257
[TBL] [Abstract][Full Text] [Related]
4. Intellectual abilities in tuberous sclerosis complex: risk factors and correlates from the Tuberous Sclerosis 2000 Study.
Bolton PF; Clifford M; Tye C; Maclean C; Humphrey A; le Maréchal K; Higgins JN; Neville BG; Rijsdjik F; ; Yates JR
Psychol Med; 2015 Aug; 45(11):2321-31. PubMed ID: 25827976
[TBL] [Abstract][Full Text] [Related]
5. Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation.
Hwang SK; Lee JH; Yang JE; Lim CS; Lee JA; Lee YS; Lee K; Kaang BK
Mol Brain; 2016 May; 9(1):56. PubMed ID: 27216612
[TBL] [Abstract][Full Text] [Related]
6. [Autism, epilepsy and tuberous sclerosis complex: a functional model linked to mTOR pathway].
García-Peñas JJ; Carreras-Sááez I
Rev Neurol; 2013 Feb; 56 Suppl 1():S153-61. PubMed ID: 23446718
[TBL] [Abstract][Full Text] [Related]
7. Is tuberous sclerosis complex-associated autism a preventable and treatable disorder?
Curatolo P; Scheper M; Emberti Gialloreti L; Specchio N; Aronica E
World J Pediatr; 2024 Jan; 20(1):40-53. PubMed ID: 37878130
[TBL] [Abstract][Full Text] [Related]
8. Brain Symptoms of Tuberous Sclerosis Complex: Pathogenesis and Treatment.
Mizuguchi M; Ohsawa M; Kashii H; Sato A
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206526
[TBL] [Abstract][Full Text] [Related]
9. Correlation of autism with temporal tubers in tuberous sclerosis complex.
Kothur K; Ray M; Malhi P
Neurol India; 2008; 56(1):74-6. PubMed ID: 18310844
[TBL] [Abstract][Full Text] [Related]
10. Tuberous sclerosis complex presenting as convulsive status epilepticus followed by hypoxic cerebropathy: A case report.
Liu X; Zhang Y; Hao Y; Chen Y; Chen C
Medicine (Baltimore); 2019 May; 98(19):e15545. PubMed ID: 31083211
[TBL] [Abstract][Full Text] [Related]
11. Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex.
Bolton PF; Park RJ; Higgins JN; Griffiths PD; Pickles A
Brain; 2002 Jun; 125(Pt 6):1247-55. PubMed ID: 12023313
[TBL] [Abstract][Full Text] [Related]
12. Epilepsy and epileptiform EEG: association with autism and language disorders.
Ballaban-Gil K; Tuchman R
Ment Retard Dev Disabil Res Rev; 2000; 6(4):300-8. PubMed ID: 11107195
[TBL] [Abstract][Full Text] [Related]
13. mTOR inhibitor improves autistic-like behaviors related to Tsc2 haploinsufficiency but not following developmental status epilepticus.
Petrasek T; Vojtechova I; Klovrza O; Tuckova K; Vejmola C; Rak J; Sulakova A; Kaping D; Bernhardt N; de Vries PJ; Otahal J; Waltereit R
J Neurodev Disord; 2021 Apr; 13(1):14. PubMed ID: 33863288
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychological aspects of tuberous sclerosis in relation to epilepsy and MRI findings.
Jambaqué I; Cusmai R; Curatolo P; Cortesi F; Perrot C; Dulac O
Dev Med Child Neurol; 1991 Aug; 33(8):698-705. PubMed ID: 1916024
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric problems in tuberous sclerosis complex.
Asato MR; Hardan AY
J Child Neurol; 2004 Apr; 19(4):241-9. PubMed ID: 15163088
[TBL] [Abstract][Full Text] [Related]
16. Epileptic spasms in tuberous sclerosis complex.
Hsieh DT; Jennesson MM; Thiele EA
Epilepsy Res; 2013 Sep; 106(1-2):200-10. PubMed ID: 23796861
[TBL] [Abstract][Full Text] [Related]
17. Mechanism-based treatment in tuberous sclerosis complex.
Jülich K; Sahin M
Pediatr Neurol; 2014 Apr; 50(4):290-6. PubMed ID: 24486221
[TBL] [Abstract][Full Text] [Related]
18. [Neuropsychiatric manifestations in Tuberous Sclerosis Complex (TSC): diagnostic guidelines, TAND concept and therapy with mTOR inhibitors].
Waltereit R; Feucht M; de Vries MC; Huemer J; Roessner V; de Vries PJ
Z Kinder Jugendpsychiatr Psychother; 2019 Mar; 47(2):139-153. PubMed ID: 30080117
[TBL] [Abstract][Full Text] [Related]
19. Associations between electroencephalographic and magnetic resonance imaging findings in tuberous sclerosis complex.
Gallagher A; Chu-Shore CJ; Montenegro MA; Major P; Costello DJ; Lyczkowski DA; Muzykewicz D; Doherty C; Thiele EA
Epilepsy Res; 2009 Dec; 87(2-3):197-202. PubMed ID: 19783123
[TBL] [Abstract][Full Text] [Related]
20. A Case of Tuberous Sclerosis Without Multiorgan Involvement.
Falsafi P; Taghavi-Zenouz A; Khorshidi-Khiyavi R; Nezami N; Estiar MA
Glob J Health Sci; 2015 Feb; 7(5):124-31. PubMed ID: 26156917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
